The role of insulin glulisine to improve glycemic control in children with diabetes mellitus
Anna Lih, Emily Hibbert, Tang Wong, Christian M Girgis, Nidhi Garg, John N CarterDepartment of Endocrinology and Metabolism, Concord Hospital, NSW, Australia; University of Sydney, Camperdown, NSW, AustraliaAbstract: Glulisine (Apidra®) is a rapid-acting human insulin analog approved for use...
Main Authors: | Carter J, Lih A, Hibbert EL, Wong T, Girgis C, Garg |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2010-11-01
|
Series: | Diabetes, Metabolic Syndrome and Obesity |
Subjects: | |
Online Access: | https://www.dovepress.com/the-role-of-insulin-glulisine-to-improve-glycemic-control-in-children--peer-reviewed-article-DMSO |
Similar Items
-
Use of human insulin analogues in young patients with type 1 diabetes mellitus: Results of the RESULT observational program on the use of insulin glargine (Lantus) in combination with insulin glulisine (Apidra) as a basal-bolus regimen
by: N V Efremova, et al.
Published: (2015-10-01) -
Analysis of Glulisine Crystallisation Utilising Phase Diagrams and Nucleants
by: Yanmin Li, et al.
Published: (2019-09-01) -
Mauriac syndrome in adult with type 1 diabetes mellitus
by: Natalya Alexandrovna Molitvoslovova, et al.
Published: (2011-09-01) -
Short-acting insulin analogues versus regular human insulin on postprandial glucose and hypoglycemia in type 1 diabetes mellitus: a systematic review and meta-analysis
by: Karla F. S. Melo, et al.
Published: (2019-01-01) -
A Difference Between Bedtime and Pre-Breakfast Plasma Glucose Levels Indicates the Need for Prandial Insulin in Basal Insulin-Treated Type 2 Diabetic Patients with Normal Fasting Glucose
by: Kress S, et al.
Published: (2021-03-01)